SEQIRUS
Seqirus has manufacturing facilities on three continents and a globally integrated supply chain to ensure that the influenza vaccine is delivered on time to customers. They have one of the industry's most extensive influenza vaccination portfolios, customized to the needs of health care providers and their patients.
SEQIRUS
Social Links:
Industry:
Health Care Manufacturing Pharmaceutical
Founded:
1916-01-01
Address:
Maidenhead, Windsor And Maidenhead, United Kingdom
Country:
United Kingdom
Website Url:
http://www.seqirus.com
Total Employee:
1001+
Status:
Active
Contact:
+44 0 1628 641500
Email Addresses:
[email protected]
Technology used in webpage:
Font Awesome Domain Not Resolving IPv6 Facebook Sharer Microsoft Microsoft Azure Lorem Ipsum Shutterstock CKEditor Add To Any
Official Site Inspections
http://www.seqirus.com Semrush global rank: 619.35 K Semrush visits lastest month: 72.15 K
- Host name: csl.com
- IP address: 12.3.33.229
- Location: Atlanta United States
- Latitude: 33.9707
- Longitude: -84.3247
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30338
More informations about "Seqirus"
Global Biotechnology Company | CSL
CSL Seqirus one of the largest influenza vaccine providers in the world and a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness.See details»
Seqirus | Latest News
CSL Seqirus, a global leader in the protection of public health, confirmed it is fully prepared to deliver its influenza vaccine portfolio for the 2025/26 Canadian influenza season, based on the …See details»
Seqirus - 2025 Company Profile, Competitors & Financials - Tracxn
Jun 25, 2025 Seqirus is a public company based in Maidenhead (United Kingdom), founded in 1916. It operates as a Developer of vaccines for influenza prevention. The company has 75 …See details»
Seqirus - Crunchbase Company Profile & Funding
Seqirus is an influenza vaccine manufacturing company.Seqirus has …See details»
Seqirus Vaccines Company Profile - Office Locations ... - Craft
Seqirus Vaccines £170 m in annual revenue in FY 2018. See insights on Seqirus Vaccines including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Seqirus 2025 Company Profile: Valuation, Investors, …
Information on acquisition, funding, investors, and executives for Seqirus. Use the PitchBook Platform to explore the full profile.See details»
CSL Seqirus | About Us
CSL Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.See details»
Member profile: Seqirus | BIA
Seqirus at a glance As one of the world’s largest influenza vaccine providers, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic …See details»
Home Page - MedComm - Seqirus
Welcome to Seqirus Medical Information self-service, document search page. Using any keywords, search our medical information documents and …See details»
CSL Seqirus | A World Leader in Influenza Vaccines
CSL Seqirus has a rich heritage in the fight against influenza. As part of CSL, our experience dates back to the deadly 1918 influenza pandemic and we’ve …See details»
CSL to Spin Off Seqirus, Cut Up to 15% of Staff in Sweeping …
SYDNEY—Vaccine and blood-products company CSL on Tuesday unveiled a sweeping corporate restructure that will include spinning off its flu-vaccine unit Seqirus and cutting up to 15% of its …See details»
CSL Seqirus Manufacturing
CSL Seqirus one of the largest influenza vaccine providers in the world and a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness.See details»
Seqirus Ready to Reinforce Canada's Influenza Pandemic
Mar 23, 2021 Seqirus Canada is an influenza pandemic vaccine partner to the Canadian Government through the Public Health Agency of Canada (PHAC).See details»
CSL Seqirus | Meet Our Leadership
CSL Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.See details»
CSL to Spin Off Vaccine Unit Seqirus, Plans $487 Million Buyback
2 days ago Australian biotech giant CSL Ltd. said it will spin off its Seqirus vaccine business into a separately listed company, as it reported full-year profit that was slightly higher than expected.See details»
Seqirus - Crunchbase Company Profile & Funding
Seqirus is an influenza vaccine company.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec et tellus vitae nunc vehicula ullamcorper. Donec sollicitudin tempus auctor. Donec ut …See details»
CSL Seqirus | Contact Us
Looking to connect with CSL Seqirus? Our global headquarters are in Maidenhead, UK, but there are many ways to connect with us around the world. Learn more.See details»
Australian biotech giant CSL to spin off vaccine unit Seqirus, cut …
2 days ago [SYDNEY] Australian biotech giant CSL said that it will spin off its Seqirus vaccine business into a separately listed company as part of a restructure that will see it reduce its …See details»
Contact Us - CSL Seqirus
CSL Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention of influenza globally, with extensive research and production expertise and …See details»
News Releases | CSL
Mar 3, 2025 Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced the completion of an expansion to the company’s manufacturing …See details»